Apr 2 |
Lexaria Awarded New Patents
|
Mar 21 |
Lexaria to Present at The LD Micro Invitational XIV
|
Mar 14 |
Lexaria appoints Nelson Cabatuan as CFO
|
Mar 14 |
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
|
Mar 12 |
Lexaria Bioscience files to sell 1.61M shares of common stock for holders
|
Mar 7 |
Lexaria Awards Contract For Next GLP-1 Human Pilot Study
|
Mar 5 |
Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes
|
Mar 5 |
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1
|
Mar 4 |
7% Weight Loss in Animals Supports Lexaria’s Next 8-week Animal Study
|
Mar 1 |
Lexaria slips despite FDA nod to test blood pressure drug
|